Pathology Doctors in Cleveland, OH Accepting Medicare

206 Pathology doctors found. Showing 201 - 206

Ram Al-sabti, Pathology - Anatomic Pathology & Clinical Pathology Medicare: May Accept Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-6046    Fax: 216-201-5354

Dr. Phillip Edward Charles, MBBS Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: Cleveland Clinic 9500 Euclid Avenue/jj24, Cleveland, OH 44195 Phone: 216-444-2200

Genevieve Marie Crane, M.D., PH.D. Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-337-1139

Gregory T Maclennan, MD Pathology - Blood Banking & Transfusion Medicine Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-7494    Fax: 216-286-6341

Gerald A Hoeltge, M.D. Pathology - Anatomic Pathology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273

Louis H. Levine, M.D. Pathology - Anatomic Pathology Medicare: Not Enrolled in Medicare Practice Location: 11100 Euclid Ave, Department Of Pathology, Cleveland, OH 44106 Phone: 216-844-8419    Fax: 216-844-1290

News Archive

Rite Aid announces proposed $650 million senior secured notes offering

Rite Aid Corporation announced today its intention to offer $650 million aggregate principal amount of senior secured notes due 2020. The notes will be unsecured, unsubordinated obligations of Rite Aid Corporation and will be guaranteed by substantially all of Rite Aid's subsidiaries. The guarantees will be secured on a senior lien basis.

Census Bureau releases report on disability status in the U.S.

About 56.7 million people ─ 19 percent of the population ─ had a disability in 2010, according to a broad definition of disability, with more than half of them reporting the disability was severe, according to a comprehensive report on this population released today by the U.S. Census Bureau.

Matrix receives FDA's tentative approval for novel co-packaged version of HIV/AIDS therapy

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) through the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine / Tenofovir Disoproxil Fumarate Tablets, 300 mg/300 mg, co-packaged with Nevirapine Tablets, 200 mg.

New blood test gives early diagnosis of neurodegenerative diseases

A new blood test that can give an early diagnosis of neurodegenerative disease and distinguish between Parkinson's and Alzheimer's disease could be launched this summer, reports Marina Murphy in SCI's Chemistry & Industry magazine.

Zero benefit of Hydroxychloroquine or Chloroquine in COVID-19, says extensive study

The purported "game-changer" anti-malarial drug Hydroxychloroquine, which was claimed to be effective in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and also helping better outcomes in COVID-19 patients, seems to have failed in clinical trials.

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11(current)